In vivo parasitological measures of artemisinin susceptibility - Wikidata - wikimedia - TriplyDB

In vivo parasitological measures of artemisinin susceptibility

In vivo parasitological measures of artemisinin susceptibility

http://www.wikidata.org/entity/Q34921155

about

Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum Spread of artemisinin resistance in Plasmodium falciparum malaria Malaria in the Greater Mekong Subregion: heterogeneity and complexity Artemisinin-resistant malaria: research challenges, opportunities, and public health implications Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems Atypical mitogen-activated protein kinase phosphatase implicated in regulating transition from pre-S-Phase asexual intraerythrocytic development of Plasmodium falciparum Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial More efficient ways of assessing treatments for neglected tropical diseases are required: innovative study designs, new endpoints, and markers of effects Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh Rapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasites Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach Efficacy of Chloroquine for the Treatment of Vivax malaria in Northwest Ethiopia Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-infer Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname.Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance Immunity as a predictor of anti-malarial treatment failure: a systematic review The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique Risk factors for Plasmodium falciparum hyperparasitaemia in malarious children Emerging artemisinin resistance in the border areas of Thailand.Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance Efficacy of artemisinin-based combination treatments of uncomplicated falciparum malaria in under-five-year-old Nigerian children.Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire.Drug-Resistant Malaria: The Era of ACT.Therapeutic efficacies of artemisinin-based combination therapies in Nigerian children with uncomplicated falciparum malaria during five years of adoption as first-line treatments.In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia.Efficacy and effectiveness of mefloquine and artesunate combination therapy for uncomplicated Plasmodium falciparum malaria in the Peruvian Amazon.Understanding genetic variation in in vivo tolerance to artesunate: implications for treatment efficacy and resistance monitoring No evidence for spread of Plasmodium falciparum artemisinin resistance to Savannakhet Province, Southern Laos.Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator

P2860

Q21032477-10F38407-7509-45B2-8CA3-8AE04BFD3117 Q21032481-CBB0683D-5845-479F-A7C5-3A1A818DF841 Q21032492-0B97E9ED-01B0-495C-9F4E-35B3B14EB291 Q21032532-DD9FA097-A11D-4830-AE4A-8EEC8C06F22B Q24598695-F956DD0A-4843-4734-BE49-5D8BF8E148BE Q24630683-D2E23090-B8A6-4538-87E5-D458049D82D8 Q26783646-1AB8D469-B949-4B8D-A4E7-C20F142A8A82 Q26783902-6E217E6C-AE75-4D1C-BA8C-B50B10623E10 Q26820807-A4451142-E133-4151-ADC7-E88FAE4A2353 Q26822489-D324179B-A8BB-4E82-8E14-E2A60D92A151 Q27000750-794832EE-E4FF-461E-831D-E04D61AA2FCC Q27974726-AB71FD1A-4C24-4182-A2B0-FB2FC8F0F3A5 Q28475290-F8978F8D-C1F4-4475-9E6A-6A9D6A62C988 Q28477892-C1D333F0-BD67-4FDE-991A-779C58E8CF6D Q28478138-554B02A0-0656-4D68-8A63-D8958C3101A0 Q28483969-3D8EB6C0-F9C5-4C0C-950C-D137BB903273 Q28484416-71F9E6D3-331D-418E-94DA-926C0449C701 Q28538245-76C88FE5-4E5F-418D-9424-80710798440D Q28546794-3B351AD2-B6C9-4F93-9105-3174DDA9D671 Q28553811-BE41F84F-D13B-49F5-A227-88AC72C00240 Q28554000-622F37CB-598E-4F67-8124-2557298BFDA3 Q28691396-D1A54DBA-350B-4E76-85E0-99CA0030BD89 Q29353547-E8BC9790-964B-4575-ADBB-0F571E994A0C Q29353565-BCBD17A9-FD7C-46C2-803D-11BA73592AD9 Q30044965-FCDBBE99-12CE-4230-9F2D-11E1DC3077BA Q33582154-D868E8E1-4318-428F-A83F-5672AE3304DA Q33655603-009BFFEC-A0FD-4A9C-A037-ACFDC8BE6992 Q34042533-3F8D5FF6-E28A-4C08-9231-87093FFEB9A6 Q34044042-C2E625F0-8DEC-42B7-BE25-3C17676A5334 Q34343530-EDAC4861-177C-4F83-9199-A48246112A50 Q34351109-F750FF0F-76F4-4AF4-B310-0A79AA54FD66 Q34496205-43481A6D-07B9-4FB1-BEE4-2EEFE1A8BBE4 Q34611124-F494594B-E251-42FC-95E5-87D9BFBBA99B Q34681141-AD6C566B-05B2-42AD-92D5-D174702F9E1E Q35031900-23D93025-5F00-4090-A810-AFD46F1D05C9 Q35186075-50202240-35CE-4428-98BF-7A8FDD341801 Q35186891-B08EBF66-8F8A-4771-A3B8-D860C35436B6 Q35236718-084B6A18-9753-4D5D-8ED5-1A6586E2651D Q35771776-53CEA5C0-84F2-45C2-8FFC-D752450D5A30 Q35834952-36B9EF74-E15F-44AD-A99F-79B5F31252A5

P2860

In vivo parasitological measures of artemisinin susceptibility

http://www.wikidata.org/entity/Q34921155

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

In vivo parasitological measures of artemisinin susceptibility

@ast

In vivo parasitological measures of artemisinin susceptibility

@en

In vivo parasitological measures of artemisinin susceptibility

@nl

type

label

In vivo parasitological measures of artemisinin susceptibility

@ast

In vivo parasitological measures of artemisinin susceptibility

@en

In vivo parasitological measures of artemisinin susceptibility

@nl

prefLabel

In vivo parasitological measures of artemisinin susceptibility

@ast

In vivo parasitological measures of artemisinin susceptibility

@en

In vivo parasitological measures of artemisinin susceptibility

@nl

P1433

Q34921155-9C8AD7BD-FBC0-47DB-9E13-43E78CEED793

P1476

Q34921155-6B954F7F-FE75-4D49-BC48-D3F5BAA55DEC

P2093

Q34921155-1056916F-16C5-4B09-BBE8-069AD86A98F7

Q34921155-1F01EFF0-29FE-4A8E-A867-46836AF5AB36

Q34921155-3F31CDCD-C033-44B5-9288-F65D4714FD20

Q34921155-4C621A1C-8B1E-42D8-B745-9CB821B4C209

Q34921155-9A761707-823C-437B-BA6F-A99D0D2D053A

Q34921155-B606E39B-28BC-4F96-945F-1DBD2D0A5419

Q34921155-C0AD89FC-32E1-47A5-BE5C-4412F011810E

Q34921155-D19D8468-034B-4D1F-A260-CA047AE870B0

Q34921155-ED642BFC-4BFA-41CA-B308-7EF1C5FBE481

P2860

Q34921155-0F283B78-ADE2-41F1-B933-E226A621B8CE

Q34921155-0FFF3F57-9763-441A-9BA5-1583B1FC3ABD

Q34921155-1537669F-77A3-4C93-AA50-E98472AB25E9

Q34921155-2336B680-02C3-42FB-9A2C-CCD00EC7371F

Q34921155-46C9E5A1-2C07-49C4-AEC7-8C03568A07BE

Q34921155-4F9278D0-21D3-4371-A0C9-6D89F88CA976

Q34921155-53E95151-5294-4F56-BF0D-91A0B751274B

Q34921155-576A0A74-63F7-46EF-9DDF-2B9A286CFA56

Q34921155-5B077381-B5BC-4421-A012-57ACBB2C7823

Q34921155-60AAC0DC-AC9B-4B56-B390-6ADC16372BE1

P304

Q34921155-D37F4279-7CA4-49E7-8131-375541B3D590

P31

Q34921155-EA8401CF-C355-462E-B15D-B63EE5031EB4

P356

Q34921155-436D8119-18F3-494D-A51F-ADCF5185DC3B

P407

Q34921155-95C10F15-B80D-4647-8B63-118CFD711DED

P433

Q34921155-264B5AFF-7F00-43C6-8084-D5C23E5B0CB0

P478

Q34921155-1DC56125-20A2-4C94-99CE-C0BF060A2314

P50

Q34921155-080A7554-AFA7-446D-8BCF-74CBF6D81E69

Q34921155-3FE183D7-0A53-4144-AE95-791F3C8A2366

Q34921155-53E20D49-5305-4268-BD5F-427B5A7B98AE

Q34921155-5AEE1C30-C553-4CA2-814C-E1A07FC3F16A

Q34921155-61638414-2BB0-43A4-806B-FB53B518B4AD

Q34921155-7609A5FC-19AF-4FB2-9D45-5BB860AE22AA

Q34921155-7BF6F0E1-61A5-493C-B90E-443A4A934EAC

Q34921155-9EB0377F-BCE9-49D9-9012-724971802AA4

Q34921155-BC0084BF-C012-4D94-8C42-553CF8DE8CB6

Q34921155-C86B455A-1630-457B-818D-D39395D05661

P577

Q34921155-5424D6EB-A447-4F4F-8581-C12208939B07

P5875

Q34921155-D8688FEE-4A73-455A-A19A-10C91938BB89

P698

Q34921155-FDA695CA-0070-438D-BCD5-97D8CF57F6E8

P921

Q34921155-F58D7F7D-F009-4D72-88E1-F4EA15C05FC4

P932

Q34921155-F9EA1B59-7235-47BC-8B0E-837392A08D4C

P356

P1433

The Journal of Infectious Diseases

P1476

In vivo parasitological measures of artemisinin susceptibility

@en

P2093

Frank Smithuis

http://www.w3.org/2001/XMLSchema#string

Jean-Paul Guthmann

http://www.w3.org/2001/XMLSchema#string

Karen I Barnes

http://www.w3.org/2001/XMLSchema#string

Paul N Newton

http://www.w3.org/2001/XMLSchema#string

Peter J de Vries

http://www.w3.org/2001/XMLSchema#string

Ric N Price

http://www.w3.org/2001/XMLSchema#string

Sue J Lee

http://www.w3.org/2001/XMLSchema#string

Tran Quang Binh

http://www.w3.org/2001/XMLSchema#string

Walter R J Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

Qinghaosu (Artemisinin): The Price of Success

Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border

Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

Antimalarial drug resistance

Artemisinin Resistance in Plasmodium falciparum Malaria

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo

Two-sided confidence intervals for the single proportion: comparison of seven methods

Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia.

Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.

P304

570-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/650301

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

201

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas John White

François H Nosten

Nicholas P J Day

Kasia Stepniewska

Umberto D'Alessandro

Nicholas M Anstey

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41087600

http://www.w3.org/2001/XMLSchema#string

P698

20085495

http://www.w3.org/2001/XMLSchema#string

P921

P932

4291277

http://www.w3.org/2001/XMLSchema#string